News
February 15, 2022

Regenstrief Research Scientist Thomas Imperiale named IU distinguished professor

Affiliate Scientist Kosali Simon also 1 of 5 recipients

Regenstrief Institute Research Scientist Thomas Imperiale, M.D., has earned Indiana University’s highest academic appointment of distinguished professor. This title recognizes faculty for their pursuit of excellence in their field.

Dr. Imperiale has conducted groundbreaking research on preventive screenings for colorectal cancer. He focuses on developing and testing screening strategies based on individual risk factors and assessing diagnostics and therapeutics. His work has strengthened the understanding of colorectal cancer and potentially saved many lives.

In addition to his role at Regenstrief, Dr. Imperiale is the Lawrence Lumeng Professor of Gastroenterology and Hepatology at the IU School of Medicine. He is also a core investigator at the VA Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center and a staff gastroenterologist serving patients in four Indiana hospitals.

He was one of five IU faculty to receive this appointment in 2022.

Affiliated Scientist Kosali Simon, PhD, also earned the designation. Her research has informed economic and healthcare policy, with a particular focus on the impact of law and policy on low-income households and people of color. She is the Herman B. Wells Endowed Professor and Paul H. O’Neill Chair at the O’Neill School of Public and Environmental Affairs at IU Bloomington.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

  • Dr. Thomas Imperiale

Related News

Regenstrief to host semiannual LOINC® conference in Washington, D.C., Sept. 17-20

Regenstrief Institute will host its semiannual LOINC® conference September 17-20, 2024, in Washington, D.C. LOINC, a global healthcare terminology

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

Published in JAMA Internal Medicine. Here is a link to the article. Regenstrief Institute author: Marianne S. Matthias, PhD

Andrew Gonzalez, MD, JD, MPH

Ensuring use of AI to improve health meets its full potential reliably and safely

Regenstrief research scientist is co-editor of National Academy of Medicine draft Code of Conduct for AI use INDIANAPOLIS –

Kathleen Unroe, M.D.

$15.5 million NIH award funds development of national network to include nursing home residents in clinical trials

INDIANAPOLIS – A team led by research scientists from the Indiana University School of Medicine and Regenstrief Institute has